MEI Pharma, Inc.
MEIP
$2.04
$0.042.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 23.74M | 26.91M | 38.35M | 56.55M | 59.48M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 1.05M | 2.81M | 6.69M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 646.00K | 840.00K | 1.37M | -- | -- |
| Total Current Assets | 24.39M | 27.75M | 40.77M | 59.37M | 66.17M |
|
|
|||||
| Total Current Assets | 24.39M | 27.75M | 40.77M | 59.37M | 66.17M |
| Net Property, Plant & Equipment | -- | 5.00K | 606.00K | 11.89M | 12.37M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 24.39M | 27.75M | 41.38M | 71.26M | 78.54M |
|
|
|||||
| Total Accounts Payable | 596.00K | 976.00K | 3.17M | 3.18M | 1.38M |
| Total Accrued Expenses | 1.69M | 1.90M | 5.19M | 5.39M | 5.65M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 1.05M | 1.02M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.29M | 2.87M | 8.36M | 9.62M | 8.04M |
|
|
|||||
| Total Current Liabilities | 2.29M | 2.87M | 8.36M | 9.62M | 8.04M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 10.62M | 11.01M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.29M | 2.87M | 8.36M | 20.23M | 19.05M |
|
|
|||||
| Common Stock & APIC | 421.00M | 421.10M | 421.24M | 420.84M | 420.17M |
| Retained Earnings | -398.90M | -396.23M | -388.22M | -369.81M | -360.69M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 22.10M | 24.88M | 33.02M | 51.03M | 59.49M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 22.10M | 24.88M | 33.02M | 51.03M | 59.49M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 22.10M | 24.88M | 33.02M | 51.03M | 59.49M |
|
|
|||||